Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients

Gene

Volumn 515, Issue 1, 2013, Pages 233-238

  El Shal, Amal S ^a   Pasha, Heba F ^a   Rashad, Nearmeen M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Egyptian population; Obesity; Resistin gene polymorphism

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADULT; ALLELES; BLOOD GLUCOSE; CASE-CONTROL STUDIES; EGYPT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RESISTIN;

EID: 84872269876     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.136     Document Type: Article

References (53)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31:55-60.
2. Angeli C.B., et al. Multilocus analyses of seven candidate genes suggest interacting pathways for obesity-related traits in Brazilian populations. Obesity 2011, 19(6):1244-1251.
3. Asano H., et al. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 2010, 53:234-246.
4. Azuma K., et al. Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm. Metab. Res. 2004, 36:564-570.
5. Barbieri M., et al. Age-related insulin Resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab. Res. Rev. 2001, 17:19-26.
6. Beckers S., et al. Analysis of genetic variations in the resistin gene shows no associations with obesity in women. Obesity 2008, 16(4):905-907.
7. Bouchard L., et al. Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study. J. Endocrinol. Invest. 2004, 27:1003-1009.
8. Chen B.H., et al. Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care 2009, 32:329-334.
9. Cho Y.M., et al. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 2004, 47:559-565.
10. Conneely K.N., et al. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 2004, 47:1782-1788.
11. Dupuis J., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010, 42:105-116.
12. _ flanking variants of resistin are associated with obesity. Diabetes 2002, 51:1629-1634.
13. Fain J.N., Cheema P.S., Bahouth S.W. Resistin release by human adipose tissue explants in primary culture. Biochem. Biophys. Res. Commun. 2003, 300:674-678.
14. Franklin C.S., et al. The TCF7L2 diabetes risk variant is associated with HbA(C) levels: a genome-wide association meta-analysis. Ann. Hum. Genet. 2010, 74:471-478.
15. Frieldewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
16. Gupta V., et al. Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome. Toxicol. Int. 2011, 18(2):168-172.
17. Heijmans B.T., et al. Meta-analysis of four new genome scans for lipid parameters and analysis of positional candidates in positive linkage regions. Eur. J. Hum. Genet. 2005, 13:1143-1153.
18. Hivert M.F., et al. Association of variants in RETN with plasma resistin levels and diabetes-related traits in the framingham offspring study. Diabetes 2009, 58(3):750-756.
19. Kaser S., Kaser A., Sandhofer A., Ebenbichler C.F., Tilg H., Patsch J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 2003, 309:286-290.
20. Kunnari A., Ukkola O., Kesäniemi Y.A. Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet. Med. 2005, 22:583-589.
21. Ma X., Warram J.H., Trischitta V., Doria A. Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 2002, 87:4407-4410.
22. Malhotra A., et al. Meta-analysis of genome-wide linkage studies of quantitative lipid traits in families ascertained for type 2 diabetes. Diabetes 2007, 56:890-896.
23. Mattevi V.S., Zembrzuski V.M., Hutz M.H. A resistin gene polymorphism is associated with body mass index in women. Hum. Genet. 2004, 115:208-212.
24. McTernan C.L., McTernan P.G., Harte A.L., Levick P.L., Barnett A.H., Kumar S. Resistin, central obesity, and type-2 diabetes. Lancet 2002, 359:46-47.
25. McTernan P.G., Kusminski C.M., Kumar S. Resistin. Curr. Opin. Lipidol. 2006, 17:170-175.
26. Menzaghi C., et al. Heritability of serum resistin and its genetic correlation with insulin resistance related features in nondiabetic Caucasians. J. Clin. Endocrinol. Metab. 2006, 91(7):2792-2795.
27. Miyamoto Y., et al. Resistin gene variations are associated with the metabolic syndrome in Japanese men. Obes. Res. Clin. Pract. 2009, 3:65-74.
28. Momiyama Y., et al. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention. J. Atheroscler. Thromb. 2010, 18(2):108-114.
29. Nogueiras R., Novelle M.G., Vazquez M.J., Lopez M., Dieguez C. Resistin: regulation of food intake, glucose homeostasis and lipid metabolism. Endocr. Dev. 2010, 17:175-184.
30. Norata G.D., Ongari M., Garlaschelli K., Raselli S., Grigore L., Catapano A.L. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur. J. Endocrinol. 2007, 156:279-284.
31. Ochi M., et al. The absence of evidence for major effects of the frequent SNP +299G > A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes. Diabetes Res. Clin. Pract. 2003, 61:191-198.
32. Ochi M., et al. Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes. Diabetes 2007, 56:2834-2838.
33. Onuma H., et al. A at single nucleotide polymorphism-358 is required for g at -420 to confer the highest plasma resistin in the general Japanese population. PLoS One 2010, 5(3):e9718.
34. Osawa H., et al. Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes 2002, 51:863-866.
35. Osawa H., et al. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am. J. Hum. Genet. 2004, 75:678-686.
36. Osawa H., et al. Plasma resistin, associated with single nucleotide polymorphism-420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 2007, 30:1501-1506.
37. Patel L., et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 2003, 300:472-476.
38. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
39. Sentinelli F., et al. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 2002, 51:860-862.
40. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27(10):2450-2457.
41. Smith S.R., Bai F., Charbonneau C., Janderova L., Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003, 52:1611-1618.
42. Steppan C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
43. Suriyaprom K., Phonrat B., Namjuntra P., Chanchay S., Tungtrongchitr R. The +299(G>A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais. J. Clin. Biochem. Nutr. 2009, 44(1):104-110.
44. Tan J.T., et al. Polymorphisms identified through genome-wide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. J. Clin. Endocrinol. Metab. 2010, 95:390-397.
45. Tang N.P., et al. A polymorphism in the resistin gene promoter and the risk of coronary artery disease in a Chinese population. Clin. Endocrinol. 2008, 68(1):82-87.
46. Tsai F.J., et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 2010, 6(2):e1000847.
47. Ukkola O., Kunnari A., Kesaniemi Y.A. Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul. Pept. 2008, 149:56-59.
48. Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
49. Wang H., Chu W.S., Hemphill C., Elbein S.C. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 2002, 87:2520-2524.
50. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
51. Youn B.S., et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes Mellitus. J. Clin. Endocrinol. Metab. 2004, 89:150-156.
52. Yu Z., Han S., Cao X., Zhu C., Wang X., Guo X. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity 2012, 20(2):396-406.
53. Zabaneh D., Balding D.J. A genome-wide association study of the metabolic syndrome in Indian Asian men. PLoS One 2010, 5(8):e11961. (5. 4).